REQUEST A DEMO
Total
USD $0.00
Search more companies

Lilly Pharmacies Ltd OOD (Аптеки Лили ООД) (Bulgaria)

Main Activities: Pharmacies and Drug Stores
Full name: Lilly Pharmacies Ltd OOD Profile Updated: February 16, 2026
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English Download a sample report

Lilly Pharmacies Ltd OOD (Аптеки Лили ООД) is an enterprise based in Bulgaria. Its main office is in Burgas. It operates in the Pharmacies and Drug Stores industry. The company was established on May 24, 2026. It currently has a total number of 25 (2023) employees.

Headquarters
Saedinenie 4, ET. 2
Burgas; Burgas; Postal Code: 8000

Contact Details: Purchase the Lilly Pharmacies Ltd OOD (Аптеки Лили ООД) report to view the information.

Basic Information
Total Employees:
Purchase the Lilly Pharmacies Ltd OOD (Аптеки Лили ООД) report to view the information.
Registered Capital:
Purchase the Lilly Pharmacies Ltd OOD (Аптеки Лили ООД) report to view the information.
Financial Auditors:
Purchase the Lilly Pharmacies Ltd OOD (Аптеки Лили ООД) report to view the information.
Incorporation Date:
May 24, 2026
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Lilly Pharmacies Ltd OOD (Аптеки Лили ООД) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Total Operating Revenue
59.87%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?